Oxidative Profile of Patients with ST Segment Elevation Myocardial Infarction

Clinical Laboratory
|June 29, 2016
PubMed

Insights

This study found that while ST-segment elevation myocardial infarction (STEMI) patients show higher oxidative stress markers than controls, the overall oxidative profile is similar between STEMI and non-STEMI patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Oxidative Stress Research

Background:

  • ST-segment elevation myocardial infarction (STEMI) involves total vessel occlusion, potentially differing in Reactive Oxygen Species (ROS) production from non-ST-segment elevation myocardial infarction (NSTEMI) with partial occlusion.
  • Understanding oxidative stress differences in acute myocardial infarction (AMI) types is crucial for patient stratification and treatment.

Purpose of the Study:

  • To compare the oxidative stress profiles of patients with STEMI and NSTEMI against healthy controls.
  • To investigate specific biomarkers of oxidative damage and antioxidant capacity in different AMI presentations.

Main Methods:

  • Analyzed 46 AMI patients (STEMI and NSTEMI) and 40 healthy controls.
  • Assessed oxidative stress markers: carbonyl protein (PCO), lipid peroxidation (TBARS), ischemia-modified albumin (IMA), vitamin C (VIT C), superoxide dismutase (SOD), and catalase (CAT).

Main Results:

  • STEMI patients exhibited significantly higher serum PCO, plasma TBARS, serum IMA, erythrocyte CAT, and SOD activity compared to controls.
  • No significant differences in IMA or other oxidative stress parameters were found between STEMI and NSTEMI conditions.
  • STEMI patients showed significantly lower plasma vitamin C levels compared to both NSTEMI patients and controls.

Conclusions:

  • The study suggests that the oxidative profile in acute myocardial infarction is comparable between STEMI and NSTEMI, irrespective of the arterial occlusion size.
  • Oxidative stress markers are elevated in STEMI compared to healthy individuals, but the distinction between STEMI and NSTEMI regarding oxidative profiles is not pronounced based on the markers assessed.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
647
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
430
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
7.5K